---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-078557"
form_type: "8-K"
ticker: "PAHC"
cik: "0001069899"
company_name: "PHIBRO ANIMAL HEALTH CORP"
filed_at: "2024-07-09T23:59:59+00:00"
generated_at: "2026-05-31T22:29:51.626805+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Phibro Animal Health enters $960M credit facility with Rabobank; delayed draw for Zoetis acquisition

## Summary
- Term A-1 loans total $351M (initial $162M + delayed $189M); Term A-2 loans total $299M.
- Revolving credit commitment of $310M; Term A-1 and Revolver mature July 2029, Term A-2 July 2031.
- Proceeds used to refinance existing debt, pay fees, and fund Zoetis Acquisition via delayed draw facilities.
- Interest rates based on Net Leverage Ratio; commitment fees 0.20%-0.35% on undrawn commitments.

## SEC filing metadata
- accession: 0001104659-24-078557
- form_type: 8-K
- ticker: PAHC
- cik: 0001069899
- company_name: PHIBRO ANIMAL HEALTH CORP
- filed_at: 2024-07-09T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1069899/000110465924078557/0001104659-24-078557-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1069899/000110465924078557/tm2419097d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-078557
- JSON: https://secwatch.observer/filing/0001104659-24-078557.json
- Plain text: https://secwatch.observer/filing/0001104659-24-078557.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.